US Ebola case boosts biotechs with treatments
October 01, 2014 at 06:07 AM EDT
Sentiment in U.S. stock futures overall was dampened early Wednesday after the U.S. confirmed its first case of Ebola. But biotech stocks were stronger.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.